Horizons Chronic Graft-Versus-Host-Disease Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 27, 2023

Primary Completion Date

December 12, 2024

Study Completion Date

December 31, 2025

Conditions
Graft Vs Host DiseaseCoping SkillsQuality of LifeStem Cell Transplant Complications
Interventions
BEHAVIORAL

Horizons Group Intervention

The Horizons Group intervention in English or Spanish language (per participant preference) contains 8 weekly group sessions delivered via video conference by a bone marrow transplant clinician and behavioral health specialist, over approximately 8 weeks, approximately 1.5 hours per session every week. The intervention pairs state-of-the-science information about survivorship and chronic graft versus host disease with self-management strategies. Intervention sessions will be delivered via video conference (Zoom), which participants may access by computer, laptop, tablet, or smart phone. As part of the intervention, participants will have access to an intervention manual and audio-recorded relaxation exercises to support learning and skills practice.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT06160986 - Horizons Chronic Graft-Versus-Host-Disease Study | Biotech Hunter | Biotech Hunter